105 related articles for article (PubMed ID: 15595646)
41. Knocking-down the expression of nucleostemin significantly decreases rate of proliferation of rat bone marrow stromal stem cells in an apparently p53-independent manner.
Jafarnejad SM; Mowla SJ; Matin MM
Cell Prolif; 2008 Feb; 41(1):28-35. PubMed ID: 18211284
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710.
Nikpour P; Mowla SJ; Jafarnejad SM; Fischer U; Schulz WA
Cell Prolif; 2009 Dec; 42(6):762-9. PubMed ID: 19706044
[TBL] [Abstract][Full Text] [Related]
43. Downregulation of human Cdc6 protein using a lentivirus RNA interference expression vector.
Luo F; Yee JK; Huang SH; Wu LT; Jong AY
Methods Mol Biol; 2006; 342():287-93. PubMed ID: 16957383
[TBL] [Abstract][Full Text] [Related]
44. Gene expression profiling of HL-60 cells following knockdown of nucleostemin using DNA microarrays.
Sun X; Jia Y; Wei Y; Liu S; Yue B
Oncol Rep; 2014 Aug; 32(2):739-47. PubMed ID: 24912530
[TBL] [Abstract][Full Text] [Related]
45. In vitro study of nucleostemin as a potential therapeutic target in human breast carcinoma SKBR-3 cells.
Guo Y; Liao YP; Zhang D; Xu LS; Li N; Guan WJ; Liu CQ
Asian Pac J Cancer Prev; 2014; 15(5):2291-5. PubMed ID: 24716972
[TBL] [Abstract][Full Text] [Related]
46. Preparation and characterization of monoclonal antibodies against nucleostemin, a protein that controls cell proliferation in stem cells and cancer cells.
Yang H; Zhang J; Wu J; Shou C
Hybridoma (Larchmt); 2005 Feb; 24(1):36-41. PubMed ID: 15785207
[TBL] [Abstract][Full Text] [Related]
47. In vitro study of Nucleostemin gene as a potential therapeutic target for human lung carcinoma.
Gao HX; Gao XF; Wang GQ; Wang ES; Huang W; Huang P
Biomed Environ Sci; 2012 Feb; 25(1):91-7. PubMed ID: 22424632
[TBL] [Abstract][Full Text] [Related]
48. Gene expression profiling of NB4 cells following knockdown of nucleostemin using DNA microarrays.
Sun X; Jia Y; Wei Y; Liu S; Yue B
Mol Med Rep; 2016 Jul; 14(1):175-83. PubMed ID: 27374947
[TBL] [Abstract][Full Text] [Related]
49. Generation of inducible shRNAi human embryonic stem cell lines.
Avery S
Curr Protoc Stem Cell Biol; 2011 Sep; Chapter 5():Unit5C.1. PubMed ID: 21913171
[TBL] [Abstract][Full Text] [Related]
50. Cell proliferation. Common control for cancer, stem cells.
Normile D
Science; 2002 Dec; 298(5600):1869. PubMed ID: 12471231
[No Abstract] [Full Text] [Related]
51. Nucleostemin mRNA is expressed in both normal and malignant renal tissues.
Fan Y; Liu Z; Zhao S; Lou F; Nilsson S; Ekman P; Xu D; Fang X
Br J Cancer; 2006 Jun; 94(11):1658-62. PubMed ID: 16670719
[TBL] [Abstract][Full Text] [Related]
52. Concomitant upregulation of nucleostemin and downregulation of Sox2 and Klf4 in gastric adenocarcinoma.
Asadi MH; Derakhshani A; Mowla SJ
Tumour Biol; 2014 Jul; 35(7):7177-85. PubMed ID: 24763828
[TBL] [Abstract][Full Text] [Related]
53. Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies.
Liu SJ; Cai ZW; Liu YJ; Dong MY; Sun LQ; Hu GF; Wei YY; Lao WD
World J Gastroenterol; 2004 May; 10(9):1246-9. PubMed ID: 15112336
[TBL] [Abstract][Full Text] [Related]
54. Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability.
Zhu Q; Yasumoto H; Tsai RY
Mol Cell Biol; 2006 Dec; 26(24):9279-90. PubMed ID: 17000763
[TBL] [Abstract][Full Text] [Related]
55. eIF3c: a potential therapeutic target for cancer.
Emmanuel R; Weinstein S; Landesman-Milo D; Peer D
Cancer Lett; 2013 Aug; 336(1):158-66. PubMed ID: 23623922
[TBL] [Abstract][Full Text] [Related]
56. Nucleophosmin is a binding partner of nucleostemin in human osteosarcoma cells.
Ma H; Pederson T
Mol Biol Cell; 2008 Jul; 19(7):2870-5. PubMed ID: 18448670
[TBL] [Abstract][Full Text] [Related]
57. Nucleostemin depletion induces post-g1 arrest apoptosis in chronic myelogenous leukemia k562 cells.
Seyed-Gogani N; Rahmati M; Zarghami N; Asvadi-Kermani I; Hoseinpour-Feyzi MA; Moosavi MA
Adv Pharm Bull; 2014; 4(1):55-60. PubMed ID: 24409410
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy.
Wei B; Huang Q; Zhong X
Onco Targets Ther; 2015; 8():1805-14. PubMed ID: 26229488
[TBL] [Abstract][Full Text] [Related]
59. Nucleostemin regulates proliferation and migration of gastric cancer and correlates with its malignancy.
Wu H; Wang W; Tong S; Wu C
Int J Clin Exp Med; 2015; 8(10):17634-43. PubMed ID: 26770353
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of nucleostemin in the cytoplasm and nuclei of normal and cancerous cell lines.
Kavyasudha C; Joel JP; Devi A
Turk J Biol; 2018; 42(3):250-258. PubMed ID: 30814887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
